- CRS Publications
- News
News
Authors:
Date:
Business Wire: September 8, 2016 – REDWOOD CITY, CA, U.S.A. – Heron Therapeutics, Inc. (NASDAQ:HRTX), a biotechnology company focused on improving the lives of patients by developing best-in-class medicines that address major unmet medical needs, announced that results from the initial portions of…
Authors:
Date:
PRNewswire: September 7, 2016 – VANCOUVER, British Columbia, Canada, and WALNUT CREEK, CA, U.S.A. – DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI) (“DelMar”), a company focused on developing and commercializing proven cancer therapies in new orphan drug indications, and Accurexa Inc. (OTCQB: ACXA) (“…
Authors:
Date:
PRNewswire: September 1, 2016 – MISSISSAUGA, Ontario, Canada – Crescita Therapeutics Inc. (TSX: CTX) (Crescita or the company), a drug development company that owns topical products for use in the treatment of medical conditions related to dermatology and pain, today announced that it has acquired…
Authors:
Date:
Business Wire: August 31, 2016 – AUSTIN, TX, U.S.A. – Caisson Biotech, LLC, has engaged Pickwick Capital Partners, LLC (member FINRA/SIPC), to assist in the sale of the HEPtune® drug-delivery platform. The proprietary platform centers on the use of a naturally occurring sugar polymer, heparosan,…
Authors:
Date:
PRNewswire: August 29, 2016 – STANS, Switzerland, Aug. 29, 2016 – NLS Pharma Group (NLS) announced today that it has initiated enrollment for its “Double-Blind Placebo-Controlled Phase II Study to Determine the Efficacy, Safety, Tolerability and Pharmacokinetics of a Controlled Release (CR)…
Authors:
Date:
PRNewswire: August 25, 2016 – WAYNE, PA, U.S.A. – Egalet Corporation (Nasdaq: EGLT) (“Egalet”), a fully integrated specialty pharmaceutical company focused on developing, manufacturing, and commercializing innovative treatments for pain and other conditions, today announced that researchers will…
